What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
Daniel E. Singer mostly deals with Internal medicine, Atrial fibrillation, Stroke, Warfarin and Cardiology.
His work carried out in the field of Internal medicine brings together such families of science as Diabetes mellitus and Endocrinology.
His Atrial fibrillation research incorporates themes from Complication, Proportional hazards model and Embolism.
His work deals with themes such as Cardioversion, Aspirin, Heart disease and Hazard ratio, which intersect with Stroke.
His studies deal with areas such as Anticoagulant, Anesthesia and Prothrombin time as well as Warfarin.
His research integrates issues of Surgery and Cohort study in his study of Risk factor.
His most cited work include:
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (6202 citations)
- Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. (4965 citations)
- A prediction rule to identify low-risk patients with community-acquired pneumonia (3543 citations)
What are the main themes of his work throughout his whole career to date?
Daniel E. Singer mainly focuses on Internal medicine, Atrial fibrillation, Cardiology, Stroke and Warfarin.
His study connects Diabetes mellitus and Internal medicine.
Daniel E. Singer has included themes like Anticoagulant, Anesthesia, Embolism and Hazard ratio in his Atrial fibrillation study.
His Cardiology study incorporates themes from Framingham Risk Score and Ischemic stroke.
The study incorporates disciplines such as Randomized controlled trial, Vitamin K antagonist, Confidence interval, Proportional hazards model and Aspirin in addition to Stroke.
His biological study deals with issues like Intensive care medicine, which deal with fields such as Community-acquired pneumonia, Emergency medicine and Clinical trial.
He most often published in these fields:
- Internal medicine (62.74%)
- Atrial fibrillation (55.32%)
- Cardiology (40.87%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (62.74%)
- Atrial fibrillation (55.32%)
- Stroke (38.97%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Atrial fibrillation, Stroke, Cardiology and Warfarin.
Rivaroxaban, Heart failure, Risk factor, Quality of life and Cohort study are the subjects of his Internal medicine studies.
His biological study spans a wide range of topics, including Clinical trial, Ischemic stroke, Cohort and Hazard ratio.
His Stroke research is multidisciplinary, relying on both Interquartile range, Oral anticoagulation, Confidence interval, Proportional hazards model and Myocardial infarction.
His work on Catheter ablation as part of general Cardiology study is frequently linked to Variation, therefore connecting diverse disciplines of science.
In his study, Patient satisfaction is strongly linked to Discontinuation, which falls under the umbrella field of Warfarin.
Between 2017 and 2021, his most popular works were:
- Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II) (82 citations)
- Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality. (37 citations)
- Association of E-Cigarette Use With Smoking Cessation Among Smokers Who Plan to Quit After a Hospitalization: A Prospective Study. (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
His main research concerns Internal medicine, Atrial fibrillation, Stroke, Cardiology and Warfarin.
His Atrial fibrillation research includes themes of Quality of life, Heart failure, Clinical trial and Emergency medicine.
His Heart failure research is multidisciplinary, incorporating elements of Cohort study and Ischemic stroke.
His Stroke research focuses on Oral anticoagulation and how it connects with Anticoagulant, Guideline and Stroke risk.
Daniel E. Singer works mostly in the field of Cardiology, limiting it down to topics relating to Risk factor and, in certain cases, Atrial flutter and Perioperative, as a part of the same area of interest.
His Warfarin study combines topics in areas such as Aspirin and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
